Member Info for uinsionn

Tagging this area, as I said earlier that’s a key area hold this or close above is a big plus

Could do with a close of 15.70, could do it, selling seems to be drying up, just need another tr1 from the buyer and away we go

Got a large holding here, looking to buy more but think we might see lower from here, but long term it’s a winner and the dividend is always a perk .

Think most of us have bought here on the lows, got a £10 average in here, I was one of the lucky ones, I sold some weeks back at £23 ad the chart looked week and sellers were all over it, now in for 2 for 1 situation. Happy to hold here until we go back into the 20s again could be 6 months could be 12 months but either way it’s been a bargain buying the lows

Have taken 4 large weights in here, probably will take some more if we get another dip tomorrow. Blackrock have closed their 2.72% short,we currently got 7% of declared shorts to close,roughly 43m shares to close,we have 2 large sellers getting near bottom & a fund buying (RNS today),shorts going to close soon before Sellers are out,don’t think they expected PI volume. This company is working hard during this pandemic, it’s on the roads, keeping the cash coming in and keeping the NHS running, offering free recovery and repair for any nhs worker at this key time, Market leader, strong board, 1 billion sales, servicing their debts, holding good cash position, bargain prices down here, hold and get rewarded.

Strong BOD here, with David hall and Jeremy Martin from hzm, great PF of assets and recent deal in Scotland looks very good with regard to gold, irish asset advanced well with zinc lead and silver, defo undervalued,

third top tier company to put money into Irish assets in the last 6 months looks like investment growth in Irish resources ,ERIS mentioned they were working on a Jv on abbeytown town,if this lands hold onto your hats,viable asset #zinc #lead #silver, now with Scottish gold and gold asset in Sweden and Finland this is massively undervalued. I have built a very strong position here over the last 12 months on the dips, ipo price was 25p, strong BOD, cash in the bank, no silly placings they have been very clever with their cash, in-house team of geos doing the work, no lifestyle ceos and Jeremy and David hall from hzm on the BOD here too.

https://www.juniorminingnetwork.com/junior-miner-news/press-releases/2078-tsx-venture/adzn/71779-adventus-and-south32-sign-earn-in-agreement-for-exploration-projects-in-ireland.html

welcome to the club yaya I have a good stake in here now, I am a large holder in HZM and a long term holder who has the luck of being average low in there, this is a great time to be building a position in IMO, think things will be great this year, esp. if we get the JV news on abbeytown, plenty to look forward to with Swedish and finland gold and now the attraction of Scottish gold too, BOD here heavily linked with HZM and david hall knows a good asset when he sees one.

Another good day here plenty of people starting to understand how undervalued this company is, with a more advanced asset incoming and a deal just announced in Scotland with a highly prospective gold area. Company working on a Jv for their commercially viable zinc asset in Ireland, plenty going on here with a strong BOD who have a proven track record of exploration, discovery and sales

Bargain buying down here really, so many assets in the PF now with gold in Sweden, Norway, Finland and now Scotland added, the abbeytown zinc asset looking great with the results and company Working on a Jv there, plenty of upside, trading below cash position and zero value for the assets, company looking to bring in a more advanced asset too, plenty going on here, nice article on the BBC.

Tissue Regenix is employing its proprietary technologies, dCELL and BioRinse, to develop a regenerative medicine business addressing a broad range of applications. The diverse product portfolio targets sizeable market opportunities in orthopaedics, spine, dental, wound/general surgery, and cardiac care settings. Last year’s acquisition of CellRight Technologies brought a complementary product line and, importantly, the production infrastructure to address the significant US market. We value, using a DCF model, the company at £245m, or 20.9p a share.

We also view TRX as an attractive takeover target for its broad innovation platform that addresses needs in various segments.”

Jefferies forecasts Tissue Regenix reporting group sales of £18mln in full-year 2019, up 53.9% year-on-year, advancing to £26mln in 2020 and £37mln in 2021.

EV/NPV multiples
In our report Gold stars and Black holes – Analysing the discount: From resource to sanction, published in January 2019, we calculated that, excluding outliers, the average value of companies with projects at PFS stage is 9.9% of attributable NPV, within a range between -15.4% and 51.3%. On the basis of Amur’s published NPVs (at US$8.00/lb Ni), this would imply a valuation for the company of US$60.8m (or 8.7c/share) based on the toll smelt option, or US$97.8m (or 14.0c/share), based on the low-grade matte option (excluding net cash/debt). However, given the strong (positive) correlation between valuations and IRRs observed in our report, coupled with both scenarios’ high IRRs, we estimate these percentages could increase to 13.0% for the toll smelt option and 15.9% for the low-grade matte option, implying valuations of US$79.9m (or 11.4c/share) and US$157.0m (or 22.5c/share), respectively. Notwithstanding these results for a project at PFS stage of development, at the BFS/DFS stage, the average enterprise value of a company typically increases from 9.9% of attributable NPV to 30.9% (within a range from -10.1% to 133.5%), which would imply a valuation for the company of US$189.9m (26.9c/share currently) based on the toll smelt option, or US$305.1m (43.3c/share currently) based on the low-grade matte option assuming that a BFS/DFS is completed as planned in 2020.

Someone looks happy to pickup anything under 5p here, metals having a bit of a spike run of late, hopefully the company working on abbeytown JV or sale as anton mentioned recently, this might unlock our ability to bring in a new asset as they mentioned, works in Sweden and Finland ongoing and cash position still strong here.

Large spread now, looks like it’s going under support

Sakiatieva in North Finland ranks as the most interesting in terms of potential for significant mineralisation. Erris Resources PLC (LON:ERRIS) wil continue with a 'disciplined approach' to expenditure on its projects in Ireland and Scandinavia given the tough backdrop for junior miners at present.

At the end of August, Erris held approximately €1.7mln in cash.

The junior has an agreement with Centerra Gold over acreage in Finland and Norway where ground-truthing and prospecting got underway at the Sakiatieva and Pirunkoukka reservation permits in Finland in June.

Erris aims to identify drill targets on one or more of the projects, which may lead to Centerra Gold electing a Designated Project Area for an earn-in.

Sakiatieva in North Finland ranks as the most interesting in terms of potential for significant mineralisation.

In Ireland, at Abbeytown, soil samples have indicated a number of new zones of mineralisation that could potentially indicate a much larger deposit.

A preliminary metallurgical study also showed good quality lead and zinc concentrates can be produced using a standard flotation process with excellent recoveries ‘while the concentrate is clean with respect to penalty elements and the grindability characteristics of the mineralised sample are positive’.

“The results further reinforce our confidence in the economic potential of the Abbeytown Project.”

At the end of August, the Company held approximately €1.7 million in cash and maintained a disciplined approach to expenditure on its 100% owned projects. Given the challenging state of the resources sector currently, the Company will maintain this approach whilst actively seeking partners for its zinc-lead projects in Ireland. At the same time, the Board and Management continue to review projects in low risk jurisdictions internationally that fit its investment criteria. Seeking partners for abbeytown could unlock cash for new assets, The Company continues to maintain its extremely disciplined approach to expenditure and cash management and as such is well funded into 2020.

Positive results very low cash burn now waiting on the Sweden Finland updates on gold Centerra Alliance - Finland and Sweden
The Company's geologists mobilised to the Sakiatieva and Pirunkoukka reservation permits in Finland to carry out prospecting and ground truthing of targets during June 2019. Mapping and prospecting was also carried out on new target areas in North Sweden. The work is fully funded as part of the Company's strategic alliance with Centerra Gold. Erris aims to identify drill targets on one or more of the projects, which may lead to Centerra Gold electing a Designated Project Area for earn-in as per the agreement signed between the two parties in December 2015. At present the Sakiatieva project in North Finland ranks as the most interesting in terms of potential for significant mineralisation. one good discovery there and we should move much higher, market not seeing the value of abbeytown yet but a Jv agreement could be forth coming anytime as the company are working on it

Looking tightly held here, interims due, expect an update on our projects in Sweden and Finland to come in the next 7days, Jv on abbeytown could land anytime, also I wonder how the company are doing on another asset, looking good from here if the company can get the right news going, so undervalued, no value on assets priced at cash. One good gold discovery in Sweden or Finland and this could really go, should be much higher anyway as the abbeytown asset has progressed well.

strong cash position" and is actively seeking new projects that fit its investment model.

The AIM traded mineral exploration company said its disciplined approach to expenditure has left it well funded for the remainder of 2019 with a £2.0m cash position.

Jeremy Martin, non-executive chairman of Erris, said: "With its strong cash position and team with a proven track record of discovery and value creation, Erris Resources continues to advance its strategy focused on value creation through exploration and discovery. In line with this, we have already demonstrated the potential of Abbeytown, and we are now reviewing other projects that fit our investment criteria in low-risk jurisdictions internationally."

Work undertaken at the Abbeytown zinc-lead-silver-copper project in Northwest Ireland has resulted in the successful delineation of new mineralisation, while the company has continued to work with TSX listed Centerra Gold in Sweden and Finland.